Brief reportMicroinjection of the L-Type Calcium Channel Antagonist Diltiazem into the Ventral Nucleus Accumbens Shell Facilitates Cocaine-Induced Conditioned Place Preferences
Section snippets
Animals and Surgery
Sixty-two male Sprague Dawley rats (300–325 g) (Charles River, Boston, Massachusetts) were used. Rats were housed individually with free access to food and water, and were maintained on a 12-hour light (0700–1900) dark cycle. Rats were anesthetized with intraperitoneal (IP) pentobarbital (65 mg/kg) supplemented with subcutaneous atropine (.25 mg/kg) to minimize bronchial secretions. Bilateral guide cannula (26-gauge) aimed 1 mm above the ventral NASh (1.5 mm anterior to bregma, ±1.0 mm from the
Results
A dose-response function for cocaine alone (5.0–20 mg/kg, IP) with intra-NASh microinjections of vehicle prior to cocaine conditioning showed that rats spent more time in cocaine-associated environments following conditioning (F1,15 = 11.7, p < .01) (Figure 1). Only rats given 20 mg/kg cocaine spent more time in cocaine-associated environments after conditioning (p < .01, Fisher’s protected t-tests). Lower doses of cocaine (5.0 and 10 mg/kg, IP) did not produce reliable effects. These data are
Discussion
Microinjections of diltiazem (10 nmol/hemisphere) into the ventral NASh shell immediately prior to systemic injection of a sub-threshold dose of cocaine (5.0 mg/kg, IP) established conditioned place preferences. The doses of diltiazem and cocaine used in combination did not have significant effects when tested alone. These effects were specific to the ventral NASh because microinjections of diltiazem into more dorsal regions did not enhance the ability of this sub-threshold dose of cocaine to
References (24)
- et al.
The many faces of CREB
Trends in Neurosci
(2005) - et al.
L-type calcium channels modulate glutamate-driven bursting activity in the nucleus accumbens in vivo
Brain Res
(2000) Calcium channelscellular roles and molecular mechanisms
Curr Opin Neurobiol
(1994)- et al.
The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine
Brain Res Bull
(1991) - et al.
Multiple types of neuronal calcium channels and their selective modulation
Trends Neurosci
(1988) Drug-activation of brain reward pathways
Drug Alcohol Depen
(1998)- et al.
Altered responsiveness to cocaine in rats exposed to methylphenidate during development
Nat Neurosci
(2002) Place conditioning to study drug reward and aversion
Meth Mol Med
(2003)- et al.
Sensitization to morphine induced by viral-mediated gene transfer
Science
(1997) - et al.
Regulation of cocaine reward by CREB
Science
(1998)
Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex
J Neurosci
Biophysical and pharmacological characterization of voltage-dependent Ca2+ channels in neurons isolated from rat nucleus accumbens
J Neurophysiol
Cited by (22)
Usage of L-type calcium channel blockers to suppress drug reward and memory driving addiction: Past, present, and future
2022, NeuropharmacologyCitation Excerpt :For example, CaV1.2 LTCCs in the NAc has been implicated in the expression of psychostimulant sensitization via recruitment of Ca2+/calmodulin-dependent kinase leading to increased surface expression of AMPA receptors in MSNs (Anderson et al., 2008; Schierberl et al., 2011). Intra-NAc administration of diltiazem, a non-dihydropyridine LTCC blocker, has been reported to suppress cocaine priming-induced reinstatement of cocaine seeking after extinction (Anderson et al., 2008), while facilitating the development of cocaine CPP (Chartoff et al., 2006). These results using diltiazem may have to be interpreted with caution, as its effect on neuronal LTCCs, especially the CaV1.3 subtype, has not been confirmed with electrophysiological recordings in neuronal preparations.
CACNA1C (Ca <inf>v</inf>1.2) in the pathophysiology of psychiatric disease
2012, Progress in NeurobiologyCitation Excerpt :In rats, administration of the hydrophobic dihydropyridine LTCC antagonist isradipine dose-dependently attenuates intake of sweetened drinking water, a rewarding liquid (Calcagnetti and Schechter, 1992), as well as the reinforcing effects of amphetamine (Pucilowski et al., 1995), while nimodipine suppresses the effect of nicotine (Biala, 2003) in conditioned place preference. Additionally, there is evidence that the LTCC antagonist D-cis-diltiazem enhances the rewarding effects of cocaine in the conditioned place preference test when injected in the ventral NAc shell (Chartoff et al., 2006). In mice sensitized to psychostimulants, increases in Cav1.2 protein levels in the frontal cortex and limbic forebrain were found (Ford et al., 2009; Shibasaki et al., 2010), as well as increased surface expression of Cav1.2 channels in pyramidal neurons of the medial prefrontal cortex (Ford et al., 2009).
Diltiazem
2009, xPharm: The Comprehensive Pharmacology ReferenceBiological substrates of reward and aversion: A nucleus accumbens activity hypothesis
2009, NeuropharmacologyCitation Excerpt :Under normal circumstances, excitatory influences mediated by glutamate actions at AMPA and NMDA receptors or dopamine actions at D1-like receptors are balanced by inhibitory dopamine actions at D2-like receptors. Treatments that would be expected to reduce activity in the NAc – including cocaine (Peoples et al., 2007), morphine (Olds 1982), NMDA antagonists (Carlezon and Wise, 1996), L-type Ca2+ antagonists (Chartoff et al., 2006), palatable food (Wheeler et al., 2008) and expression of dominant-negative CREB (Dong et al., 2006) – have reward-related effects because they reduce the inhibitory influence of the NAc on downstream reward pathways. In contrast, treatments that activate the NAc by amplifying glutamatergic inputs (e.g., elevated expression of GluR1; Todtenkopf et al., 2006), altering ion channel function (e.g., elevated expression of CREB: Dong et al., 2006), reducing inhibitory dopamine inputs to D2-like cells (e.g., κ-opioid receptor agonists), or blocking inhibitory μ- or δ-opioid receptors (West and Wise, 1988; Weiss, 2004) are perceived as aversive because they increase the inhibitory influence of the NAc on downstream reward pathways.
L-Type Calcium Channel Blockers: A Potential Novel Therapeutic Approach to Drug Dependence
2021, Pharmacological Reviews